Data is not available at this time.
Emergency Assistance Japan Co., Ltd. operates in the healthcare assistance sector, specializing in medical and lifestyle support services for individuals and organizations in Japan and internationally. The company’s core offerings include emergency medical assistance, security management, and tailored support programs for foreign nationals and students, leveraging its proprietary Assistance Cloud platform. This positions it as a niche provider in Japan’s growing healthcare and safety management market, where demand for specialized assistance services is rising due to an aging population and increasing cross-border mobility. The company differentiates itself through integrated solutions that combine technology with human expertise, catering to both corporate clients and individual subscribers. While it faces competition from larger healthcare and insurance providers, its focus on emergency response and localized support services provides a defensible market position.
The company reported revenue of ¥2.91 billion for FY 2024, with net income of ¥48 million, reflecting tight margins in a competitive assistance services market. Operating cash flow was negative at ¥-39.8 million, though capital expenditures remained modest at ¥-13 million. The diluted EPS of ¥19.05 suggests moderate earnings power relative to its share count, but profitability metrics indicate room for operational improvements.
With a market capitalization of ¥2.61 billion, the company’s earnings yield is relatively low, reflecting its niche scale and competitive pressures. The negative operating cash flow raises questions about near-term capital efficiency, though its high cash balance (¥2.3 billion) provides a buffer. The balance between debt (¥1.18 billion) and liquidity suggests manageable leverage but limited flexibility for aggressive expansion.
Emergency Assistance Japan maintains a solid liquidity position with ¥2.3 billion in cash against ¥1.18 billion in total debt, indicating a conservative leverage profile. The negative operating cash flow in FY 2024 warrants monitoring, but the company’s strong cash reserves mitigate immediate solvency risks. Its ability to sustain dividend payments (¥13 per share) despite weak cash generation highlights reliance on balance sheet strength.
Revenue growth appears stagnant, with profitability constrained by operating inefficiencies. The dividend payout, while modest, may not be sustainable if cash flow trends do not improve. The company’s focus on digital assistance platforms (e.g., Assistance Cloud) could drive future growth, but execution risks remain given its small scale and competitive industry dynamics.
Trading at a beta of 0.635, the stock exhibits lower volatility than the broader market, likely due to its defensive healthcare sector exposure. The current valuation reflects muted growth expectations, with investors likely prioritizing stability over expansion. A re-rating would require demonstrated improvements in cash flow generation or scalable customer acquisition.
The company’s specialized assistance services and technology integration provide a competitive edge in Japan’s niche emergency support market. However, its outlook depends on operational turnaround and broader adoption of its cloud-based solutions. Demographic trends (aging population, international mobility) support long-term demand, but near-term challenges in profitability and cash flow generation remain key hurdles.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |